4DMedical (4DX.AX) Earnings Analysis
4DMedical (4DX.AX) next reports earnings on 2026-08-27, consensus EPS -0.0405 AUD. Last quarter (2026-02-26) it missed with EPS -0.259 AUD vs -0.0362 AUD est (-615.5%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -10.02.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4DX.AX next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | -0.0405 AUD |
| Revenue estimate | 0.01B |
4DX.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.259 AUD | -0.0362 AUD | -615.5% | Miss |
| 2025-08-28 | -0.01328 AUD | n/a | n/a | n/a |
| 2025-03-03 | -0.031 AUD | -0.04 AUD | +22.5% | Beat |
| 2024-09-30 | -0.04964 AUD | n/a | n/a | n/a |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
4DX.AX valuation and analyst view
| Trailing P/E | -10.02 |
|---|---|
| Trailing EPS | -0.322 AUD |
| Price / book | -56.54 |
| Dividend yield | 0.00% |
| Market cap | 2.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is 4DMedical (4DX.AX)'s next earnings date?
4DMedical is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.0405 AUD and revenue estimate of 0.01B.
Did 4DX.AX beat earnings last quarter?
In its 2026-02-26 report, 4DX.AX posted EPS of -0.259 AUD versus a -0.0362 AUD estimate — a miss of 615.5%.
What is 4DX.AX's earnings track record?
Over the last 2 reported quarters with consensus data, 4DX.AX beat estimates 1 times (50%).
What is 4DX.AX's current P/E ratio and EPS?
4DX.AX trades at a trailing P/E of -10.02 on trailing EPS of -0.32199833862314764 AUD.
What do analysts rate 4DX.AX?
4DX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.